Sterling Investment Counsel, LLC 9 Meters Biopharma, Inc. Transaction History

Sterling Investment Counsel, LLC

  • $254 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022
SELL
$0.26 - $0.64 $4,558 - $11,221
-17,533 Closed
0 $0
Q1 2022

May 10, 2022
BUY
$0.52 - $1.0 $2,600 - $5,000
5,000 Added 39.89%
17,533 $11,000
Q4 2021

Apr 29, 2022
BUY
$0.85 - $1.33 $10,653 - $16,668
12,533 New
12,533 $12,000

Others Institutions Holding NMTR

# of Institutions
4
Shares Held
73.4K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Sterling Investment Counsel, LLC Portfolio

Follow Sterling Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Investment Counsel, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email